Monoclonal Mouse anti‑Human Herpesvirus 8 HHV‑8 K8 alpha Antibody (clone 8C12G10G1, IHC, WB) LS‑C41377
Monoclonal Mouse anti‑Human Herpesvirus 8 HHV‑8 K8 alpha Antibody (clone 8C12G10G1, IHC, WB) LS‑C41377
Antibody:
HHV-8 K8 alpha Mouse anti-Human Herpesvirus 8 Monoclonal (8C12G10G1) Antibody
Application:
IHC, ICC, WB, ELISA
Reactivity:
Human Herpesvirus 8
Format:
Unconjugated, Unmodified
Overview
Antibody:
HHV-8 K8 alpha Mouse anti-Human Herpesvirus 8 Monoclonal (8C12G10G1) Antibody
Application:
IHC, ICC, WB, ELISA
Reactivity:
Human Herpesvirus 8
Format:
Unconjugated, Unmodified
Specifications
Description
HHV-8 K8 alpha antibody LS-C41377 is an unconjugated mouse monoclonal antibody to human herpesvirus 8 HHV-8 K8 alpha. Validated for ELISA, ICC, IHC and WB.
Target
Human Herpesvirus 8 HHV-8 K8 alpha
Reactivity
Human Herpesvirus 8
(tested or 100% immunogen sequence identity)
Clonality
IgG2a
Monoclonal
Conjugations
Unconjugated
Immunogen
Purified recombinant fragment of KSHV K8a expressed in E. Coli.
Applications
- IHC
- ICC
- Western blot (1:100 - 1:500)
- ELISA (1:10000)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Presentation
Ascitic fluid, 0.03% sodium azide
Storage
Short term: store at 4°C. Long term: store at -20°C.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human Herpesvirus 8
Applications:
IHC, ICC, Western blot
Species:
Virus
Applications:
IHC, Western blot
Reactivity:
Human
Range:
78-5000 pg/ml
Reactivity:
Rat
Range:
0.156-10 ng/ml
Reactivity:
Human
Range:
0.312-20 ng/ml
Reactivity:
Mouse
Range:
0.156-10 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 9/20/2024